Diabetic retinopathy is a common complication of diabetes, which manifests as a potentially severe eye disease that can lead ...

Breye Therapeutics has announced that danegaptide, a potential oral treatment for nonproliferative diabetic retinopathy, has ...

A diabetic eye screening appointment usually takes about 30 minutes: We’ll ask you to read some letters on a chart. We’ll put drops in your eyes. These may sting for a few seconds and may make your ...

Danegaptide, a potential oral therapy for nonproliferative diabetic retinopathy, is advancing to a phase 2 trial after ...

Doctors in India are constantly raising alarms over the rise in cases of vision loss among those battling type 2 diabetes—mostly due to a lack of early screening, poor blood sugar control, and delayed ...

Many people with diabetes have the earliest stage of diabetic retinopathy, called mild nonproliferative diabetic retinopathy (NPDR), without even knowing it, according to the American Academy of ...

According to Varma, African Americans have a high rate of visual impairment and are especially likely to develop open-angle ...

India, often labelled the diabetic capital of the world, faces an alarming crisis with over 77 million people diagnosed with ...

Microaneurysm (MA) turnover increases with the progression of nonproliferative diabetic retinopathy (NPDR) and is correlated with presence of intraretinal microvascular abnormalities (IRMAs), ...

Diabetic retinopathy (DR) is an eye-related complication that can occur in people who have diabetes. It affects blood vessels in the retina - the "light-sensitive layer of tissue in the back of ...